EUVIMEDEUVIMED entdecken
Crossref

Efficacy of Prophylactic Tranexamic Acid in Preventing Postpartum Hemorrhage after Vaginal Delivery: Evidence from a Randomized Controlled Study

N R Ramya, R Navyashree, K Ganesh Kamath, Sally Mary Abraham, K Sridevi, S Akshatha

Annals of African Medicine · 07.04.2026

DOI: 10.4103/aam.aam_692_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of African Medicine, online erschienen am 07.04.2026. Verfasst von N R Ramya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, Yenepoya Medical College, Mangalore, Karnataka, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Postpartum hemorrhage (PPH) is a primary cause of maternal mortality, accounting for 35% of maternal deaths globally. Active management of the third stage of labor (AMTSL) is a prophylactic intervention recommended by the World Health Organization for the prevention of PPH. Antifibrinolytic therapy with tranexamic acid (TXA) offers a potential strategy to minimize blood loss by inhibiting fibrin degradation.

Aims

This study aims to compare the efficacy and safety of parenteral oxytocin with a low dose of TXA versus oxytocin administered within 2 min after vaginal delivery in the prevention of PPH. Subjects and Methods: This randomized controlled study was conducted among 488 participants in a tertiary teaching center. Participants were randomly assigned to two groups to compare the effect of injection Oxytocin + injection TXA (1 g) versus injection Oxytocin after vaginal delivery in preventing postpartum hemorrhage. The incidence of PPH, reduction in hemoglobin and hematocrit values, proportion of women requiring supplementary uterotonics treatment, and incidence of postpartum transfusion were assessed.

Results

There were no notable differences between the two groups with regard to demographic data. The average expected blood loss is significantly lower among the test (Oxytocin + TXA) group, M = 321.1066, compared to the control (only Oxytocin) group, M = 503.0738, which depicted comparatively higher blood loss. P < 0.01 at 99% confidence interval. Hemoglobin level of the tested groups ( M = 12.0545) was found to be comparatively higher than that of the control groups.

Conclusions

The findings of our study indicate that the use of oxytocin with TXA is more effective in preventing PPH and minimizing blood loss compared to oxytocin alone.

Schlagwörter

Stichwörter der Autor:innen

Maternal healthSantéaccouchement par voie basseacide tranexamiquehémorragie du post-partummaternelleocytocineoxytocinpostpartum hemorrhagetranexamic acidvaginal delivery

Autor:innen und Institutionen

  • Department of Obstetrics and Gynaecology, Yenepoya Medical College, Mangalore, Karnataka, India.
  • Department of Pharmacology, Yenepoya Medical College, Mangalore, Karnataka, India.
  • Department of Cardiothoracic and Vascular Surgery, Yenepoya Medical College, Mangalore, Karnataka, India.
  • Department of Obstetrics and Gynaecology, Nectar Mother and Care Hospital, Bengaluru, Karnataka, India.

Zitieren

APA

Ramya, N. R., Navyashree, R., Kamath, K. G., Abraham, S. M., Sridevi, K., & Akshatha, S. (2026). Efficacy of Prophylactic Tranexamic Acid in Preventing Postpartum Hemorrhage after Vaginal Delivery: Evidence from a Randomized Controlled Study. Annals of African Medicine. https://doi.org/10.4103/aam.aam_692_25

Vancouver

Ramya NR, Navyashree R, Kamath KG, Abraham SM, Sridevi K, Akshatha S. Efficacy of Prophylactic Tranexamic Acid in Preventing Postpartum Hemorrhage after Vaginal Delivery: Evidence from a Randomized Controlled Study. Annals of African Medicine. 2026. doi:10.4103/aam.aam_692_25

BibTeX
@article{Ramya2026,
  author = {Ramya, N R and Navyashree, R and Kamath, K Ganesh and Abraham, Sally Mary and Sridevi, K and Akshatha, S},
  title = {Efficacy of Prophylactic Tranexamic Acid in Preventing Postpartum Hemorrhage after Vaginal Delivery: Evidence from a Randomized Controlled Study},
  journal = {Annals of African Medicine},
  year = {2026},
  doi = {10.4103/aam.aam_692_25}
}
Kostenlos starten →